Possibility of the regression of atherosclerosis through the prevention of endothelial senescence by the regulation of nitric oxide and free radical scavengers

Geriatrics and Gerontology International

Volumn 10, Issue 2, 2010, Pages 115-130

  Hayashi, Toshio ^a   Iguchi, Akihisa ^a,b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI SHUKUTOKU UNIVERSITY   (Japan)

Author keywords

Cellular senescence; Endothelial cells; Endothelial nitric oxide synthase; Hyperglycemia; Nitric oxide

Indexed keywords

ADENOVIRUS VECTOR; APOCYNIN; ARGINASE; ARGINASE 2; CALCIUM CHLORIDE; CITRULLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTRADIOL; ESTRIOL; ESTROGEN; ESTROGEN RECEPTOR; GLYCERYL TRINITRATE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; N(G) NITROARGININE; N(G) NITROARGININE ACETATE ESTER; NITRIC OXIDE; OXIDOREDUCTASE INHIBITOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCAVENGER; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CELL AGING; CEREBROVASCULAR ACCIDENT; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DISEASE CLASSIFICATION; DISEASE COURSE; DOWN REGULATION; DRUG MECHANISM; DYSLIPIDEMIA; ELDERLY CARE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME INHIBITION; GENE TARGETING; HEART INFARCTION; HORMONE INHIBITION; HUMAN; HYPEREMIA; HYPERGLYCEMIA; MENOPAUSE; MOLECULAR INTERACTION; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS REGULATION; REMISSION; REVIEW; RISK FACTOR; VIRAL GENE DELIVERY SYSTEM;

AGED; AGING; ANIMALS; CAROTID ARTERY DISEASES; CELLS, CULTURED; DIABETIC ANGIOPATHIES; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ESTROGENS; HUMANS; NITRIC OXIDE; REACTIVE OXYGEN SPECIES;

EID: 77952468298     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2009.00581.x     Document Type: Review

References (96)

1. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986, 314:488-500.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
3. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999, 340:115-126.
4. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 288:373-376.
5. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999, 399:601-605.
6. Drummond GR, Cai H, Davis ME, Ramasamy S, Harrison DG. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res 2000, 86:347-354.
7. Neumann P, Gertzberg N, Johnson A. TNF-alpha induces a decrease in eNOS promoter activity. Am J Physiol Lung Cell Mol Physiol 2004, 286:L452-L459.
8. Laufs U, Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho. GTPase. J Biol Chem 1998, 273:24266-24271.
9. Sumi D, Hayashi T, Matsui-Hirai H, Jacobs AT, Ignarro LJ, Iguchi A. 17beta-estradiol inhibits NADPH oxidase activity through the regulation of p47phox mRNA and protein expression in THP-1 cells. Biochim Biophys Acta 2003, 1640:113-118.
10. Dudzinski DM, Michel T. Life history of eNOS: partners and pathways. Cardiovasc Res 2007, 75:247-260.
11. Levine YC, Li GK, Michel T. Agonist-modulated regulation of AMP-activated protein kinase (AMPK) in endothelial cells. Evidence for an AMPK/Rac1/Akt/ endothelial nitric-oxide synthase pathway. J Biol Chem 2007, 282:20351-20364.
12. Buga GM, Gold ME, Fukuto JM, Ignarro LJ. Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension 1991, 17:187-193.
13. Jayachandran M, Hayashi T, Sumi D, Iguchi A, Miller VM. Temporal effects of 17beta-estradiol on caveolin-1 mRNA and protein in bovine aortic endothelial cells. Am J Physiol Heart Circ Physiol 2001, 281:H1327-H1333.
14. Ignarro LJ, Buga GM, Wei LH, Bauer PM, Wu G, del Soldato P. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc Natl Acad Sci USA 2001, 98:4202-4208.
15. Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res 1995, 76:980-986.
16. Böger RH, Bode-Böger SM, Mügge A. Supplementation of hypercholesterolaemic rabbits with l-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 1995, 117:273-284.
17. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989, 65:1-21.
18. Hayashi T, Ishikawa T, Naito M. Low level hyperlipidemia impairs endothelium-dependent relaxation of porcine coronary arteries by two mechanisms. Functional change in endothelium and impairment of endothelium-dependent relaxation by two mediators. Atherosclerosis 1991, 87:23-38.
19. Hayashi T, Ignarro LJ, Fukuto JM, Chaudhuti G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci USA 1992, 89:11259-11263.
20. Guzik TJ, Mussa S, Gastaldi D. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002, 105:1656-1662.
21. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000, 87:840-844.
22. Kume N, Kita T. Apoptosis of vascular cells by oxidized LDL: involvement of caspases and LOX-1 and its implication in atherosclerotic plaque rupture. Circ Res 2004, 94:269-270.
23. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998, 93:229-240.
24. Hayashi T, Sumi D, Juliet PA. Gene transfer of endothelial NO synthase, but not eNOS plus inducible NOS, regressed atherosclerosis in rabbits. Cardiovasc Res 2004, 61:339-351.
25. Crabtree MJ, Smith CL, Lam G, Goligorsky MS, Gross SS. Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS. Am J Physiol Heart Circ Physiol 2008, 294:H1530-H1540.
26. Hayashi T, Juliet PA, Miyazaki-Akita A. Beta1 antagonist and beta2 agonist, celiprolol, restores the impaired endothelial dependent and independent responses and decreased TNFalpha in rat with type II diabetes. Life Sci 2007, 80:592-599.
27. Hata Y, Mabuchi H, Saito Y. Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias. Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults. J Atheroscler Thromb 2002, 9:1-27.
28. Tsunekawa T, Hayashi T, Iguchi A. Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days. Circulation 2001, 104:376-379.
29. Hulley S, Grady D, Bush T. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998, 280:605-613.
30. Rossouw JE, Anderson GL, Prentice RL. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333.
31. Stampfer MJ, Colditz GA, Willett WC. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med 1991, 325:756-762.
32. Anderson GL, Limacher M, Assaf AR. Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004, 291:1701-1712.
33. Kang BM, Kim MR, Park HM. Attitudes of Korean clinicians to post- menopausal hormone therapy after the Women's Health Initiative study. Menopause 2006, 13:125-129.
34. Hayashi T, Jayachandran M, Sumi D. Physiological concentration of 17beta-estradiol retards the progression of severe atherosclerosis induced by a high-cholesterol diet plus balloon catheter injury: role of NO. Arterioscler Thromb Vasc Biol 2000, 20:1613-1621.
35. Hayashi T, Kano H, Sumi D. The long-term effect of estriol on endothelial function and bone mineral density in octogenarian women. J Am Geriatr Soc 2002, 50:777-778.
36. Gesierich A, Niroomand F, Tiefenbacher CP. Role of human GTP cyclohydrolase I and its regulatory protein in tetrahydrobiopterin metabolism. Basic Res Cardiol 2003, 98:69-75.
37. Heitzer T, Krohn K, Albers S, Meinnertz T. Tetrahydrobiopterin improves endothelin-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus. Diabetologia 2000, 43:1435-1438.
38. Ding QF, Hayashi T, Packiasamy AR. The effect of high glucose on NO and O2- through endothelial GTPCH1 and NADPH oxidase. Life Sci 2004, 75:3185-3194.
39. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 1978, 89:157-161.
40. Hayashi T, Yamada K, Esaki T. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun 1995, 214:847-855.
41. Simoncini T, Hafezu-Moghadam A, Brazil DP. Interaction of oeestrogen receptor with the regulatory subunit of phosphatidylinositol-OH kinase. Nature (Lond) 2000, 47:538-541.
42. Miyazaki-Akita A, Hayashi T, Ding QF. 17β-Estradiol antagonizes the down-regulation of endothelial nitric-oxide synthase and GTP cyclohydrolase I by high glucose: relevance to postmenopausal diabetic cardiovascular disease. J Pharmacol Exp Ther 2007, 320:591-598.
43. Hayashi T, Ishikawa T, Yamada K. Biphasic effect of estrogen on neuronal constitutive nitric oxide synthase via Ca(2+)-calmodulin dependent mechanism. Biochem Biophys Res Commun 1994, 203:1013-1019.
44. Nathan L, Pervin S, Singh R, Rosenfeld M, Chaudhuri G. Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo: possible mechanisms for gender differences in atherosclerosis. Circ Res 1999, 85:377-385.
45. Fukuto JM, Chaudhuri G. Inhibition of constitutive and inducible nitric oxide synthase: potential selective inhibition. Annu Rev Pharmacol Toxicol 1995, 35:165-194.
46. Jenkinson CP, Grody WW, Cederbaum SD. Comparative properties of arginases. Comp Biochem Physiol B Biochem Mol Biol 1996, 114:107-132.
47. Esaki T, Hayashi T, Yamada K, Iguchi A. Expression of inducible nitric oxide synthase in T lymphocytes and macrophages of cholesterol-fed rabbits. Atherosclerosis 1997, 128:39-46.
48. Pegg AE, McCann PP. Polyamine metabolism and function. Am J Physiol 1982, 243:C212-C221.
49. Hecker M, Sessa WC, Harris HJ, Anggård EE, Vane JR. The metabolism of l-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle l-citrulline to l-arginine. Proc Natl Acad Sci USA 1990, 87:8612-8616.
50. Hayashi T, Juliet PA, Matsui-Hirai H. L-Citrulline and l-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits. Proc Natl Acad Sci USA 2005, 102:13681-13686.
51. Hayashi T, Esaki T, Sumi D, Mukherjee T, Iguchi A, Chaudhuri G. Modulating role of estradiol on arginase II expression in hyperlipidemic rabbits as an atheroprotective mechanism. Proc Natl Acad Sci USA 2006, 103:10485-10490.
52. Cathcart MK. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis. Arterioscler Thromb Vasc Biol 2004, 24:23-28.
53. Segal AW, Abo A. The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem Sci 1993, 18:43-47.
54. Kadri-Hassani N, Leger CL, Descomps B. The fatty acid bimodal action on superoxide anion production by human adherent monocytes under phorbol 12-myristate 13-acetate or diacylglycerol activation can be explained by the modulation of protein kinase C and p47phox translocation. J Biol Chem 1995, 270:15111-15118.
55. Juliet PA, Hayashi T, Iguchi A, Ignarro LJ. Concomitant production of nitric oxide and superoxide in human macrophages. Biochem Biophys Res Commun 2003, 310:367-370.
56. Frank PG, Woodman SE, Park DS, Lisanti MP. Caveolin, caveolae, and endothelial cell function. Arterioscler Thromb Vasc Biol 2003, 23:1161-1168.
57. Hayashi T, Juliet PA, Miyazaki A, Ignarro LJ, Iguchi A. High glucose downregulates the number of caveolae in monocytes through oxidative stress from NADPH oxidase: implications for atherosclerosis. Biochim Biophys Acta 2007, 1772:364-372.
58. Hayashi T, Juliet PA, Kano-Hayashi H. NADPH oxidase inhibitor, apocynin, restores the impaired endothelial-dependent and -independent responses and scavenges superoxide anion in rats with type 2 diabetes complicated by NO dysfunction. Diabetes Obes Metab 2005, 7:334-343.
59. Hayashi T, Yano K, Matsui-Hirai H. Nitric oxide and endothelial cellular senescence. Pharmacol Ther 2008, 120:333-339.
60. Raju SV, Barouch LA, Hare JM. Nitric oxide and oxidative stress in cardiovascular aging. Sci Aging Knowledge Environ 2005, 21:re4.
61. Reuben DB, Greendale GA, Harrison GC. Nutritional screening in older persons. J Am Geriatr Soc 1995, 43:415-425.
62. Hayashi T, Nomura H, Osawa M, Funami J, Miyazaki A, Iguchi A. Nitric oxide metabolites are associated with survival in older patients. J Am Geriatr Soc 2007, 55:1398-1403.
63. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961, 25:585-621.
64. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
65. Gire V, Roux P, Wynford-Thomas D, Brondello JM, Dulic V. DNA damage checkpoint kinase Chk2 triggers replicative senescence. EMBO J 2004, 23:2554-2563.
66. Parrinello S, Samper E, Krtolica A, Goldstein J, Melov S, Campisi J. Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol 2003, 5:741-747.
67. Bringold F, Serrano M. Tumor suppressors and oncogenes in cellular senescence. Exp Gerontol 2000, 35:317-329.
68. Toussaint O, Medrano EE, von Zglinicki T. Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp Gerontol 2000, 35:927-945.
69. Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 2005, 37:961-976.
70. Chen J, Goligorsky MS. Premature senescence of endothelial cells: Methusaleh's dilemma. Am J Physiol 2006, 290:H1729-H1739.
71. Hoffmann J, Haendeler J, Aicher A. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res 2001, 89:709-715.
72. Hayashi T, Matsui-Hirai H, Miyazaki-Akita A. Endothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes. Proc Natl Acad Sci USA 2006, 103:17018-17023.
73. Minamino T, Miyauchi H, Yoshida T. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 2002, 105:1541-1544.
74. Sato I, Morita I, Kaji K. Reduction of nitric oxide producing activity associated with in vitro aging in cultured human umbilical vein endothelial cells. Biochem Biophys Res Commun 1993, 195:1070-1076.
75. der Loo B, Labugger R, Skepper JN. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med 2000, 192:1731-1744.
76. Donato AJ, Eskurza I, Silver AE. Direct evidence of endothelial oxidative stress with aging in humans. Relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-κB. Circ Res 2007, 100:1659-1666.
77. Barton M, Cosentino F, Brandes RP. Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelin. Hypertension 1997, 30:817-824.
78. Azumi H, Inoue N, Ohashi Y. Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase. Arterioscler Thromb Vasc Biol 2002, 22:1838-1844.
79. Sorescu D, Weiss D, Lassègue B. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 2002, 105:1429-1435.
80. Ignarro LJ, Napoli C. Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis. Curr Atheroscler Rep 2004, 6:281-287.
81. Vasa M, Breitschopf K, Zeiher AM, Dimmeler S. Nitric oxide activates telomerase and delays endothelial cell senescence. Circ Res 2000, 87:540-542.
82. Fukatsu A, Hayashi T, Miyazaki-Akita A. Possible usefulness of apocynin, an NADPH oxidase inhibitor, for nitrate tolerance: prevention of NO donor-induced endothelial cell abnormalities. Am J Physiol 2007, 293:H790-H797.
83. Chan SRWL, Blackburn EH. Telomeres and telomerase. Phil Trans R Soc Lond B Biol Sci 2004, 359:109-121.
84. Karlseder J, Smogorzewska A, de Lange T. Senescence induced by altered telomere state, not telomere loss. Science 2002, 295:2446-2449.
85. Stewart SA, Ben-Porath I, Carey VJ. Erosion of the telomeric single-strand overhang at replicative senescence. Nat Genet 2003, 33:492-496.
86. Franco S, Segura S, Riese HH, Blasco MA. Decreased B16F10 melanoma growth and impaired vascularization in telomerase-deficient mice with critically short telomeres. Cancer Res 2002, 62:552-559.
87. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976, 85:447-452.
88. Best PJ, Berger PB, Miller VM, Lerman A. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med 1998, 128:285-288.
89. Hwang J, Mack WJ, Xiang M. Long-term effect of estrogen replacement on plasma nitric oxide levels: results from the estrogen in the prevention of atherosclerosis trial (EPAT). Atherosclerosis 2005, 181:375-380.
90. Lind L. Lipids and endothelium-dependent vasodilation: a review. Lipids 2002, 37:1-15.
91. Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 2004, 63:582-592.
92. Haendeler J, Hoffmann J, Diehl JF. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ Res 2004, 94:768-775.
93. Breitschopf K, Zeiher AM, Dimmeler S. Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism. FEBS Lett 2001, 493:21-25.
94. Rössig L, Fichtlscherer B, Breitschopf K. Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem 1999, 274:6823-6826.
95. Goodwin BL, Solomonson LP, Eichler DC. Argininosuccinate synthase expression is required to maintain nitric oxide production and cell viability in aortic endothelial cells. J Biol Chem 2004, 279:18353-18360.
96. Potente M, Urbich C, Sasaki K. Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest 2005, 115:2382-2392.